Elevance Health
1,665 hedge funds and large institutions have $88.7B invested in Elevance Health in 2025 Q1 according to their latest regulatory filings, with 218 funds opening new positions, 653 increasing their positions, 541 reducing their positions, and 135 closing their positions.
61% more first-time investments, than exits
New positions opened: 218 | Existing positions closed: 135
36% more call options, than puts
Call options by funds: $801M | Put options by funds: $588M
21% more repeat investments, than reductions
Existing positions increased: 653 | Existing positions reduced: 541
16% more capital invested
Capital invested by funds: $76.5B → $88.7B (+$12.2B)
13% more funds holding in top 10
Funds holding in top 10: 38 → 43 (+5)
4% more funds holding
Funds holding: 1,605 → 1,665 (+60)
0.07% more ownership
Funds ownership: 89.69% → 89.75% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$673M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$353M |
| 3 |
BlackRock
New York
|
+$349M |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$273M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$268M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$592M |
| 2 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$357M |
| 3 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$357M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$260M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$227M |
ELV Hedge Fund Activity: Q1 2025 in Review
1,665 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2025, worth a combined $88.7B — up 16% from $76.5B a quarter earlier.
Buyers outnumbered sellers: 218 funds opened new ELV positions and 135 closed out — a net gain of 83 holders — while 653 added to existing stakes and 541 trimmed.
The largest buyer was Capital International Investors, adding an estimated $673M. The largest seller was T. Rowe Price Associates, cutting an estimated $592M.
- 1,665 institutional investors held Elevance Health (ELV) as of Q1 2025, up from 1,605 in Q4 2024.
- Funds reported $88.7B of Elevance Health stock for Q1 2025, up 16% quarter-over-quarter.
- 218 funds opened new Elevance Health positions in Q1 2025 and 135 closed out, a net change of +83 holders.
- The largest Elevance Health buyer in Q1 2025 was Capital International Investors, an estimated $673M added.
- The largest Elevance Health seller in Q1 2025 was T. Rowe Price Associates, an estimated $592M sold.
Based on aggregated 13F filings for Q1 2025.